Visia Lab

Visia Lab has rapidly established itself since its founding in 2020 as an innovator in the design and production of advanced hardware/software solutions for clinical laboratory diagnostics. The company’s products are used globally across cytodiagnostics, cytogenetics, digital pathology/tele-pathology, immunoassays including immunofluorescence assays, big data analytics for genetics/genomics testing. They have built strong commercial partnerships with distributors and maintain collaborations with scientific institutes and universities. No information about clinical trials or therapeutic results applies as they do not develop drugs.